1 Meningococcal Group B Vaccine Market Overview
1.1 Product Overview and Scope of Meningococcal Group B Vaccine
1.2 Meningococcal Group B Vaccine Segment by Type
1.2.1 Global Meningococcal Group B Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Meningococcal Group B Vaccine Segment by Application
1.3.1 Global Meningococcal Group B Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Public
1.3.3 Private
1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Group B Vaccine Revenue 2017-2028
1.4.2 Global Meningococcal Group B Vaccine Sales 2017-2028
1.4.3 Meningococcal Group B Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028 2 Meningococcal Group B Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Meningococcal Group B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Meningococcal Group B Vaccine Market Competitive Situation and Trends
2.5.1 Meningococcal Group B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
2.5.3 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Meningococcal Group B Vaccine Retrospective Market Scenario by Region
3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.3.1 North America Meningococcal Group B Vaccine Sales by Country
3.3.2 North America Meningococcal Group B Vaccine Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
3.4.1 Europe Meningococcal Group B Vaccine Sales by Country
3.4.2 Europe Meningococcal Group B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region
3.5.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Meningococcal Group B Vaccine Sales by Country
3.6.2 Latin America Meningococcal Group B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country
3.7.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE 4 Global Meningococcal Group B Vaccine Historic Market Analysis by Type
4.1 Global Meningococcal Group B Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Meningococcal Group B Vaccine Price by Type (2017-2022) 5 Global Meningococcal Group B Vaccine Historic Market Analysis by Application
5.1 Global Meningococcal Group B Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Meningococcal Group B Vaccine Price by Application (2017-2022) 6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates 7 Meningococcal Group B Vaccine Manufacturing Cost Analysis
7.1 Meningococcal Group B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Meningococcal Group B Vaccine
7.4 Meningococcal Group B Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Meningococcal Group B Vaccine Distributors List
8.3 Meningococcal Group B Vaccine Customers 9 Meningococcal Group B Vaccine Market Dynamics
9.1 Meningococcal Group B Vaccine Industry Trends
9.2 Meningococcal Group B Vaccine Market Drivers
9.3 Meningococcal Group B Vaccine Market Challenges
9.4 Meningococcal Group B Vaccine Market Restraints 10 Global Market Forecast
10.1 Meningococcal Group B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Type (2023-2028)
10.2 Meningococcal Group B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Application (2023-2028)
10.3 Meningococcal Group B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Meningococcal Group B Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Meningococcal Group B Vaccine by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
